Paul Tudor Jones Quotient LTD Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 14, 2020	SELL	$3.64 - $9.26 $217,708 - $553,840	-59,810 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.54 - $9.38 $71,153 - $262,761	-28,013 Reduced 31.9%	59,810 $236,000
Q4 2019 Feb 14, 2020	BUY	$7.07 - $9.51 $158,672 - $213,432	22,443 Added 34.33%	87,823 $835,000
Q3 2019 Nov 14, 2019	BUY	$7.77 - $11.26 $259,984 - $376,759	33,460 Added 104.82%	65,380 $508,000
Q2 2019 Aug 14, 2019	BUY	$7.91 - $10.25 $252,487 - $327,180	31,920 New	31,920 $298,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.